426 related articles for article (PubMed ID: 21497747)
21. EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells.
Mimche PN; Lee CM; Mimche SM; Thapa M; Grakoui A; Henkemeyer M; Lamb TJ
Sci Rep; 2018 Feb; 8(1):2532. PubMed ID: 29416088
[TBL] [Abstract][Full Text] [Related]
22. Anti-fibrotic treatments for chronic liver diseases: The present and the future.
Odagiri N; Matsubara T; Sato-Matsubara M; Fujii H; Enomoto M; Kawada N
Clin Mol Hepatol; 2021 Jul; 27(3):413-424. PubMed ID: 33317250
[TBL] [Abstract][Full Text] [Related]
23. Hepatic regeneration and the epithelial to mesenchymal transition.
Xue ZF; Wu XM; Liu M
World J Gastroenterol; 2013 Mar; 19(9):1380-6. PubMed ID: 23538893
[TBL] [Abstract][Full Text] [Related]
24.
Hsu WH; Liao SC; Chyan YJ; Huang KW; Hsu SL; Chen YC; Siu ML; Chang CC; Chung YS; Huang CF
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137784
[TBL] [Abstract][Full Text] [Related]
25. Molecular and cellular mechanisms of liver fibrosis and its regression.
Kisseleva T; Brenner D
Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):151-166. PubMed ID: 33128017
[TBL] [Abstract][Full Text] [Related]
26. Cellular sources of extracellular matrix in hepatic fibrosis.
Wells RG
Clin Liver Dis; 2008 Nov; 12(4):759-68, viii. PubMed ID: 18984465
[TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis.
Iwasaki A; Sakai K; Moriya K; Sasaki T; Keene DR; Akhtar R; Miyazono T; Yasumura S; Watanabe M; Morishita S; Sakai T
J Biol Chem; 2016 Jan; 291(1):72-88. PubMed ID: 26553870
[TBL] [Abstract][Full Text] [Related]
28. Origin and function of myofibroblasts in the liver.
Wells RG; Schwabe RF
Semin Liver Dis; 2015 May; 35(2):97-106. PubMed ID: 25974896
[TBL] [Abstract][Full Text] [Related]
29. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.
de Oliveira da Silva B; Ramos LF; Moraes KCM
Cell Biol Int; 2017 Sep; 41(9):946-959. PubMed ID: 28498509
[TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular mechanisms in liver fibrogenesis.
Novo E; Cannito S; Paternostro C; Bocca C; Miglietta A; Parola M
Arch Biochem Biophys; 2014 Apr; 548():20-37. PubMed ID: 24631571
[TBL] [Abstract][Full Text] [Related]
31. PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.
Martin K; Pritchett J; Llewellyn J; Mullan AF; Athwal VS; Dobie R; Harvey E; Zeef L; Farrow S; Streuli C; Henderson NC; Friedman SL; Hanley NA; Piper Hanley K
Nat Commun; 2016 Aug; 7():12502. PubMed ID: 27535340
[TBL] [Abstract][Full Text] [Related]
32. [Cellular mechanism in the fibrogenesis of liver fibrosis].
You H; Sun YM
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):563-4. PubMed ID: 23227528
[No Abstract] [Full Text] [Related]
33. Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies.
Iredale JP; Pellicoro A; Fallowfield JA
Dig Dis; 2017; 35(4):310-313. PubMed ID: 28467988
[TBL] [Abstract][Full Text] [Related]
34. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.
Povero D; Pinatel EM; Leszczynska A; Goyal NP; Nishio T; Kim J; Kneiber D; de Araujo Horcel L; Eguchi A; Ordonez PM; Kisseleva T; Feldstein AE
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184999
[TBL] [Abstract][Full Text] [Related]
35. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis.
Novo E; di Bonzo LV; Cannito S; Colombatto S; Parola M
Int J Biochem Cell Biol; 2009 Nov; 41(11):2089-93. PubMed ID: 19782946
[TBL] [Abstract][Full Text] [Related]
36. Autophagy: a multifaceted partner in liver fibrosis.
Mallat A; Lodder J; Teixeira-Clerc F; Moreau R; Codogno P; Lotersztajn S
Biomed Res Int; 2014; 2014():869390. PubMed ID: 25254217
[TBL] [Abstract][Full Text] [Related]
37. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy.
Li D; Friedman SL
J Gastroenterol Hepatol; 1999 Jul; 14(7):618-33. PubMed ID: 10440206
[TBL] [Abstract][Full Text] [Related]
38. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
[TBL] [Abstract][Full Text] [Related]
39. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis.
Kisseleva T; Cong M; Paik Y; Scholten D; Jiang C; Benner C; Iwaisako K; Moore-Morris T; Scott B; Tsukamoto H; Evans SM; Dillmann W; Glass CK; Brenner DA
Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9448-53. PubMed ID: 22566629
[TBL] [Abstract][Full Text] [Related]
40. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
